Company Stock Price of Kindred Healthcare, Inc. (KND) Decreases -3.51%

Kindred Healthcare, Inc. stock performance trend indicates that the stock price has rallied 1.85% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -19.28% . Looking at the past 52 week period, the stock price is down -31.42% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Kindred Healthcare, Inc. has a negative value of -54.95 compared to overall market performance.Kindred Healthcare, Inc. is having a Relative Strength Index of 51.78 which indicates the stock is not yet over sold or over bought based on the technical indicators.

Kindred Healthcare, Inc. (NYSE:KND) has tumbled 3.51% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 13.79% in the last four weeks. The stocks have underperformed the S&P 500 by 3.74% during the past week but Kindred Healthcare, Inc. (NYSE:KND) it has outperformed the index in 4 weeks by 12.5%.

Company shares have received an average consensus rating of Hold for the current week Kindred Healthcare, Inc. (NYSE:KND) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.15 points or 1.79% at $8.25 with 1,403,039 shares getting traded. Post opening the session at $8.4, the shares hit an intraday low of $8.2 and an intraday high of $8.45 and the price was in this range throughout the day. The company has a market cap of $702 million and the number of outstanding shares has been calculated to be 85,127,745 shares. The 52-week high of Kindred Healthcare, Inc. (NYSE:KND) is $15.66 and the 52-week low is $5.65.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by Mizuho on Feb 28, 2017 to Neutral, Raises Price Target to $ 8.50 from a previous price target of $5 .

Company has reported several Insider transactions to the SEC, on Jun 29, 2016, John Joseph Lucchese (SVP & Chief Accounting Officer) sold 4,341 shares at 11.39 per share price.On Nov 12, 2015, Paul J Diaz (director) purchased 50,000 shares at 12.53 per share price.On Aug 31, 2015, Benjamin A Breier (President & CEO) sold 5,400 shares at 20.57 per share price.

Kindred Healthcare Last issued its quarterly earnings results on Feb 27, 2017. The company reported $0.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.11. Analyst had a consensus of $0.07. The company had revenue of $1745.95 million for the quarter, compared to analysts expectations of $1733.08 million. The companys revenue was down -2.0 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.44 EPS.

Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business.

Kindred

Leave a Reply

Your email address will not be published. Required fields are marked *